SCHEMBL4744831

SCHEMBL4744831

O=C(Nc1ccccc1F)C1CC1

nearest known ligand 0.67

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.67
▸ TSHR P16473 1/20 0.67
▸ KMT2A Q03164 4/20 0.62
▸ MEN1 O00255 2/20 0.62
▸ ALDH1A1 P00352 2/20 0.62
▸ L3MBTL1 Q9Y468 1/20 0.62
▸ GAA P10253 2/20 0.61
▸ POLB P06746 1/20 0.61
▸ NPC1 O15118 3/20 0.60
▸ RAB9A P51151 2/20 0.60
▸ RXFP1 Q9HBX9 1/20 0.59
▸ HDAC3 O15379 1/20 0.58
▸ HDAC1 Q13547 1/20 0.58
▸ HDAC2 Q92769 1/20 0.58
▸ LMNA P02545 1/20 0.56
▸ PKM P14618 1/20 0.55
▸ CETP P11597 1/20 0.54
▸ EPHX2 P34913 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL43074 0.93 HDAC3 (0.69) SMN1; SMN2TSHRKMT2AMEN1ALDH1A1
SCHEMBL13972908 0.92 SMN1; SMN2 (0.59) SMN1; SMN2TSHRKMT2AMEN1ALDH1A1
SCHEMBL13703413 0.91 HDAC3 (0.71) SMN1; SMN2TSHRKMT2AMEN1ALDH1A1
SCHEMBL13588433 0.89 SMN1; SMN2 (0.59) SMN1; SMN2TSHRKMT2AMEN1ALDH1A1
SCHEMBL16669873 0.82 ALDH1A1 (0.67) ALDH1A1GAAPOLBRXFP1HDAC3
SCHEMBL3335404 0.81 HDAC1 (0.84) SMN1; SMN2KMT2AMEN1ALDH1A1GAA
SCHEMBL13003435 0.81 TSHR (0.65) SMN1; SMN2TSHRKMT2AMEN1ALDH1A1
SCHEMBL13204287 0.81 TSHR (0.58) SMN1; SMN2TSHRKMT2AMEN1ALDH1A1
SCHEMBL10114769 0.81 TSHR (0.58) SMN1; SMN2TSHRKMT2AMEN1ALDH1A1
SCHEMBL10114312 0.81 TSHR (0.58) SMN1; SMN2TSHRKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008099165-A1 PIPERIDINE DERIVATIVES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES ASTRAZENECA AB (SE) 2008-08-21 — — WO disclosed
Send feedback